Skip to main content

Table 1 Evidence on the skeletal effects of Ejiao

From: Ejiao as a preventive agent for osteoporosis - a scoping review of current evidence

Researchers

Study Design

Findings

Chang et al. (2009) [35]

Model: Osteoblasts from one-day-old Wistar rat calvaria

Treatment: Serum from Wistar rats fed with Ejiao (1, 2, 4 g/kg) to Wistar rats for 3 days

Osteoblast proliferation: NS

Intracellular ALP level: ↑ vs. blank control

Gao et al. (2004) [36]

Animals: Female Sprague-Dawley rats (13–14 weeks old)

Disease model: Bone defect with three 0.8 mm holes on left tibia

Treatment: Ejiao oral solution (0.45 g/2 mL, p.o., twice daily) for 4, 7, 14, 21 and 28 days

Negative control: Distilled water

Positive control: NA

Osteoblast proliferation: NS vs. negative control

Intracellular ALP level: ↑ vs. negative control

Procollagen mRNA expression (types I, II, III): ↑ vs. negative control

TGF-β1 mRNA expression: ↑ vs. negative control

BMP-2 mRNA expression: NS vs. negative control

VEGF mRNA expression: NS vs. negative control

Chin et al. (2023) [38]

Animals: Female Sprague-Dawley rats (3 months old)

Disease model: OVX-induced osteoporosis

Treatment: Ejiao (0.26, 0.53 and 1.06 g/kg, p.o., 8 weeks)

Negative control: distilled water

Positive control: 1% calcium carbonate (oral)

Osteocyte number: NS vs. negative control

Skeletal mineral/matrix ratio: NS vs. negative control

Skeletal DKK1 and sclerostin level: NS vs. negative control

Ekeuku et al. (2023) [18]

Animals: Female Sprague-Dawley rats (3 months old)

Disease model: OVX-induced osteoporosis

Treatment: Ejiao (0.26, 0.53 and 1.06 g/kg, p.o., 8 weeks)

Negative control: distilled water

Positive control: 1% calcium carbonate (oral)

Bone mineral density and content, NS vs. negative control

Bone histomorphometry

Bone structural indices, NS vs. negative control

Bone dynamic indices, ↓ mineralising surface/bone surface ratio vs. negative control

Bone cellular indices, NS vs. negative control

Bone mechanical strength, NS vs. negative control

Bone remodelling markers, ↓circulating osteocalcin and CTX-1 with high-dose Ejiao

Ekeuku et al. (2023) [40]

Animals: Female Sprague-Dawley rats (3 months old)

Disease model: OVX-induced osteoporosis

Treatment: Ejiao (0.26, 0.53 and 1.06 g/kg, p.o., 8 weeks)

Negative control: distilled water

Positive control: 1% calcium carbonate (oral)

Total body mass: ↑ in all groups except control and calcium

Fat mass and fat percentage: ↑ in the OVX groups, regardless of treatments

Lean mass: ↑ in the OVX groups, regardless of treatments

Bone marrow adiposity: ↓ in low and medium-dose Ejiao and calcium groups vs. negative control

PPAR-γ levels: ↓ in Ejiao and calcium groups vs. negative control

Catalase, superoxide dismutase, glutathione peroxidase: ↑ vs. negative control

Glutathione: ↓ vs. negative control

Malondialdehyde: NS vs. negative control

  1. Abbreviations: ALP, Alkaline phosphatase; BMP-2, Bone morphogenetic protein-2; CTX-1, C-terminal telopeptide of type I collagen; DKK1, Dickkopf-1; NA, Not available; NS, Not significant; OVX, Ovariectomy; p.o., per-oral; PPAR-γ, Peroxisome proliferator-activated receptor gamma; TGF-β1, Transforming growth factor beta-1; VEGF, Vascular endothelial growth factor; ↑, increase or upregulate↓, decrease or downregulate